Creation and validation of an extended‐spectrum beta‐lactamase‐producing <i>Enterobacterales</i> (ESBL‐E) clinical risk scoring tool for select <i>Enterobacterales</i> in non‐urinary isolates
The majority of ESBL-E risk factor scoring tools are specific to isolates causing bloodstream infections. This institution-specific scoring tool may be used to tailor empiric antimicrobial regimens and decrease unnecessary exposure to carbapenems in non-ESBL-E infections of non-urinary origin.
Authors
- Taylor Morrisette (ORCID: https://orcid.org/0000-0002-1094-043X)
- Jordan Jones (ORCID: https://orcid.org/0000-0002-2767-0704)
- Rachel Burgoon (ORCID: https://orcid.org/0000-0003-3291-7174)
- Krutika Mediwala Hornback (ORCID: https://orcid.org/0000-0002-3982-2103)
- Aaron Hamby (ORCID: https://orcid.org/0000-0003-2600-7393)
Institutions
- Medical University of South Carolina (US)
Publication Details
- Journal
- Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
- Published
- 2025-01-10
- DOI
- https://doi.org/10.1002/phar.4646
- Citations
- 1
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 0.59